# Q/C Technologies, Inc. (QCLS) · Edgar & Edgarette company card

> Q/C Technologies (QCLS) saw revenue fall 5.3% in FY2019 to $2 million, operating margin -220% against a -4.3% median for in vitro & in vivo diagnostic substances, equity -21.4% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1321834 · fiscal year ended 2019-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/QCLS) · [JSON](https://www.pops4.com/boards/company/QCLS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $2M |
| Revenue growth, 1 year | -5.3% |
| Revenue growth per year | -7.1% |
| Operating margin | -220.2% (prior year -604.0%) |
| Net margin | -246.6% |
| Operating cash flow | −$3M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $517,444 |
| Long-term debt | — |
| Total assets | $11M |
| Total equity | −$2M |
| Equity ÷ assets | -21.4% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -34.27 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Beneish M: -3.97 (below the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · filed late annual report notice, late quarterly report notice, auditor change in the last 12 months; operating cash flow was negative (-$9.1M in FY2025); revenue is hard to predict: its 80% range is ±67%

## Edgarette's reading

Exposure: revenue $1.6M (FY2019). Experience: revenue down 5.3% on the year, down 7.1% a year over 4 years; operating margin -220.2%, up from -604.0%. Soundness: equity -21.4% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $608K and $3.1M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $544K to $3.4M. A statistical range, not company guidance. Against peers (161 filers, $50M+ revenue, its industry group): operating margin -220.2% against a -4.3% median; growth -5.3% against 12.6%.

## Health Watch, last 12 months

- Item NT 10-K Late annual report notice: 1, latest 2026-03-31 ([filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315226014222/0001493152-26-014222-index.htm))
- Item NT 10-Q Late quarterly report notice: 1, latest 2025-11-14 ([filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315225023598/0001493152-25-023598-index.htm))
- Item 4.01 Auditor change: 1, latest 2026-03-13 ([filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315226010070/0001493152-26-010070-index.htm))
- Item 5.02 Director or officer change: 4, latest 2026-09-18 ([filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315226043401/0001493152-26-043401-index.htm))

## Recent filings

- 8-K · filed 2026-09-18 · 1.01 Entry into a Material Definitive Agreement; 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315226043401/0001493152-26-043401-index.htm)
- 8-K · filed 2026-09-11 · 1.02 Termination of a Material Definitive Agreement; 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315226042394/0001493152-26-042394-index.htm)
- 10-Q · filed 2026-08-12 · [filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315226037333/0001493152-26-037333-index.htm)
- 8-K · filed 2026-07-02 · 1.02 Termination of a Material Definitive Agreement; 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315226031946/0001493152-26-031946-index.htm)
- 10-Q · filed 2026-05-15 · [filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315226023751/0001493152-26-023751-index.htm)
- 10-K · filed 2026-04-15 · [filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315226016872/0001493152-26-016872-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001321834.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1321834

## Cite

POPS4, Edgar & Edgarette: Q/C Technologies, Inc. (QCLS) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/QCLS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Its latest audited year is FY2025, which reports no revenue; the revenue figures and the range here are from FY2019, its last year with revenue on record. Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.